Global clinical trial solutions. Real-world results.
- Solutions
- Science Library
- Support
- Partners
- About Us
- Blog
The Common Stock of BioClinica, Inc. is listed on the NASDAQ Global Market under the symbol BIOC.
SIC Number: 8071
CIK Number: 0000822418
CUSIP Number: 09071B 100
Share Data at March 31,2010
Authorized: 36,000,000
Outstanding: 15,149,187
Symbol: BIOC
Exchange: NASDAQ
BioClinica will host second quarter financial results conference call on August 4, 2010 at 11:00am EDT. Click on the image below to listen to the WebCast.
For more investment information, please contact us at ir@bioclinica.com
Click here to view our Transfer Agent, Company Counsel and Independent Auditors.